Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

ClinicalTrials.gov ID: NCT00941798

Public ClinicalTrials.gov record NCT00941798. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 1:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multi-center, Parallel Group, Double Blind, Study to Assess the Safety of QMF Twisthaler® (500/400 µg) and Mometasone Furoate Twisthaler® (400 µg) in Adolescent and Adult Patients With Persistent Asthma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study CQMF149A2210 evaluated the safety of QMF149 Twisthaler® 500/400 μg, a fixed dose combination of indacaterol 500 μg, a once daily β2 agonist, and mometasone furoate 400 μg, an inhaled corticosteroid (ICS) that is approved for use in the treatment of asthma. The objective of this safety trial was to assess the effect of treatment on the incidence of serious asthma exacerbations, defined as asthma related hospitalization and/or intubation and/or death. This was an event driven trial.

Study identification

NCT ID
NCT00941798
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
2,283 participants

Conditions and interventions

Conditions

Eligibility (public fields only)

Age range
12 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2009 (Type not available)
Primary completion
May 2011 (Actual)
Completion
May 2011 (Actual)
Last update posted
Aug 31, 2012

2009 – 2011

United States locations

U.S. sites
92
U.S. states
34
U.S. cities
83
Facility City State ZIP Site status
Novartis Investigator Site Birmingham Alabama 35209 —
Novartis Investigator Site Buena Park California 90620 —
Novartis Investigator Site Encinitas California 92024 —
Novartis Investigator Site Fullerton California 92835 —
Novartis Investigator Site Long Beach California 90808 —
Novartis Investigator Site Los Angeles California 90025 —
Novartis Investigator Site Orange California 92868 —
Novartis Investigator Site Riverside California 92506 —
Novartis Investigator Site San Diego California 92123 —
Novartis Investigator Site San Jose California 95117 —
Novartis Investigator Site San Mateo California 94401 —
Novartis Investigator Site Vista California 92083 —
Novartis Investigator Site Walnut Creek California 94598 —
Novartis Investigator Site Denver Colorado 80230 —
Novartis Investigator Site Engelwood Colorado 80112 —
Novartis Investigator Site Lakewood Colorado 80401 —
Novartis Investigator Site Wheat Ridge Colorado 80033 —
Novartis Investigator Site Clearwater Florida 33756 —
Novartis Investigator Site Clearwater Florida 33765 —
Novartis Investigative Site Miami Florida 33136 —
Novartis Investigative Site Miami Florida 33157 —
Novartis Investigator Site Port Charlotte Florida 33952 —
Novartis Investigator Site Sarasota Florida 34233 —
Novartis Investigative Site South Miami Florida 33143 —
Novartis Investigator Site Tampa Florida 33603 —
Novartis Investigative Site Albany Georgia 31707 —
Novartis Investigative Site Columbus Georgia 31904 —
Novartis Investigative Site Savannah Georgia 31406 —
Novartis Investigator Site Couer D'Alene Idaho 83814 —
Novartis Investigator Site Chicago Illinois 60612 —
Novartis Investigator Site Normal Illinois 61761 —
Novartis Investigator Site River Forest Illinois 60305 —
Novartis Investigator Site Skokie Illinois 60076 —
Novartis Investigator Site Springfield Illinois 62703 —
Novartis Investigator Site Evansville Indiana 47713 —
Novartis Investigator Site Indianapolis Indiana 46208 —
Novartis Investigator Site Iowa City Iowa 52240 —
Novartis Investigator Site Topeka Kansas 66606 —
Novartis Investigator Site Owensboro Kentucky 42301 —
Novartis Investigator Site Metarie Louisiana 70002 —
Novartis Investigative Site Bangor Maine 04401 —
Novartis Investigative Site Baltimore Maryland 21236 —
Novartis Investigative Site Baltimore Maryland 21237 —
Novartis Investigative Site North Dartmouth Massachusetts 02747 —
Novartis Investigator Site Minneapolis Minnesota 55402 —
Novartis Investigator Site Plymouth Minnesota 55441 —
Novartis Investigator Site Ozark Missouri 65721 —
Novartis Investigator Site Rolla Missouri 65401 —
Novartis Investigator Site St Louis Missouri 63141 —
Novartis Investigator Site Warrensburg Missouri 64093 —
Novartis Investigator Site Bellevue Nebraska 68123 —
Novartis Investigator Site Omaha Nebraska 68130 —
Novartis Investigator Site Omaha Nebraska 68131 —
Novartis Investigative Site Brick New Jersey 08724 —
Novartis Investigative Site Cedar Knolls New Jersey 07927 —
Novartis Investigative Site Skillman New Jersey 08558 —
Novartis Investigator Site Albuquerque New Mexico 87108 —
Novartis Investigative Site Mineola New York 11501 —
Novartis Investigative Site Newburgh New York 12550 —
Novartis Investigative Site Rochester New York 14618-2638 —
Novartis Investigative Site High Point North Carolina 27262 —
Novartis Investigative site Raleigh North Carolina 27607 —
Novartis Investigator Site Canton Ohio 44718 —
Novartis Investigator Site Columbus Ohio 43213 —
Novartis Investigator Site Marion Ohio 43302 —
Novartis Investigator Site Sylvania Ohio 43560 —
Novartis Investigative Site Oklahoma City Oklahoma 73104 —
Novartis Investigator Site Oklahoma City Oklahoma 73112 —
Novartis Investigator Site Oklahoma City Oklahoma 73120 —
Novartis Investigator Site Portland Oregon 97213 —
Novartis Investigative Site Blue Bell Pennsylvania 19422 —
Novartis Investigative Site Philadelphia Pennsylvania 19115 —
Novartis Investigative site Philadelphia Pennsylvania 19140 —
Novartis Investigative Site Pittsburgh Pennsylvania 15221 —
Novartis Investigator Site Lincoln Rhode Island 02865 —
Novartis Investigative Site Mt. Pleasant South Carolina 29464 —
Novartis Investigator Site Kingsport Tennessee 37660 —
Novartis Investigator Site Dallas Texas 75230 —
Novartis Investigator Site Dallas Texas 75231 —
Novartis Investigator Site Dickinson Texas 77539 —
Novartis Investigator Site El Paso Texas 79925 —
Novartis Investigator Site Fort Worth Texas 76132 —
Novartis Investigative Site Houston Texas 77030 —
Novartis Investigator Site Houston Texas 77054 —
Novartis Investigator Site New Braunfels Texas 78130 —
Novartis Investigator Site San Antonio Texas 78229 —
Novartis Investigative Site South Burlington Vermont 05403 —
Novartis Investigative Site Abingdon Virginia 24210 —
Novartis Investigator Site Kirkland Washington 98034 —
Novartis Investigator Site Seattle Washington 98105 —
Novartis Investigator Site Tacoma Washington 98405 —
Novartis Investigator Site Milwaukee Wisconsin 53209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 54 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00941798, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 31, 2012 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00941798 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →